Cargando…

Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach

Nonalcoholic fatty liver disease (NAFLD) is becoming the most prevalent liver disease worldwide, associated with epidemics of overweight and resulting metabolic syndrome (MetS). Around 20–30% of patients with NAFLD develop progressive liver fibrosis, which is the most important predictor of liver-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grgurevic, Ivica, Podrug, Kristian, Mikolasevic, Ivana, Kukla, Michal, Madir, Anita, Tsochatzis, Emmanuel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995480/ https://www.ncbi.nlm.nih.gov/pubmed/32051820 http://dx.doi.org/10.1155/2020/9181368

Ejemplares similares

Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal
por: Bozic, Dorotea, et al.
Publicado: (2022)

CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE
por: Virović Jukić, Lucija, et al.
Publicado: (2021)

Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease
por: Pastrovic, Frane, et al.
Publicado: (2022)

Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography
por: Podrug, Kristian, et al.
Publicado: (2021)

Liver and Nonliver-Related Outcomes at 2 Years Are Not Influenced by the Results of the FIB-4 Test and Liver Elastography in a Real-Life Cohort of Patients with Type 2 Diabetes
por: Grgurevic, Ivica, et al.
Publicado: (2021)

Hepatitis C is now curable, but what happens with cirrhosis and portal hypertension afterwards?
por: Grgurevic, Ivica, et al.
Publicado: (2017)

The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
por: Mikolasevic, Ivana, et al.
Publicado: (2022)

Detection of Sarcopenia in Patients with Liver Cirrhosis Using the Bioelectrical Impedance Analysis
por: Bozic, Dorotea, et al.
Publicado: (2023)

Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study
por: Madir, Anita, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease – a growing public health problem
por: Mikolašević, Ivana, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease - A multisystem disease?
por: Mikolasevic, Ivana, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease – a procoagulant condition?
por: Virović-Jukić, Lucija, et al.
Publicado: (2021)

Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach
por: Grgurevic, Ivica, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2020)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Prognostic Factors in Primary Biliary Cholangitis: A Retrospective Study of Joint Slovak and Croatian Cohort of 249 Patients
por: Gazda, Jakub, et al.
Publicado: (2021)

The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status
por: Stojic, Josip, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2018)

Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease
por: Augustyn, Monika, et al.
Publicado: (2019)

Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease—Is There a Link?
por: Orlić, L., et al.
Publicado: (2014)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy
por: Tsochatzis, Emmanuel A., et al.
Publicado: (2009)

Nonalcoholic fatty liver disease (NAFLD) – a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients
por: Mikolasevic, Ivana, et al.
Publicado: (2014)

Liver regeneration as treatment target for severe alcoholic hepatitis
por: Virovic-Jukic, Lucija, et al.
Publicado: (2022)

Underrated enemy – from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract
por: Derra, Aleksandra, et al.
Publicado: (2018)

Chemerin as a Potential Marker of Resolution of Inflammation in COVID-19 Infection
por: Sulicka-Grodzicka, Joanna, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
por: Magrì, Salvatore, et al.
Publicado: (2019)

Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications
por: Kizivat, Tomislav, et al.
Publicado: (2020)

New Perspectives in Pediatric Nonalcoholic Fatty Liver Disease: Epidemiology, Genetics, Diagnosis, and Natural History
por: Ko, Jae Sung
Publicado: (2019)

Implications of comorbidities in nonalcoholic fatty liver disease
por: Song, Sherlot Juan, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
por: Targher, Giovanni
Publicado: (2020)

Natural history of nonalcoholic fatty liver disease: A prospective follow‐up study with serial biopsies
por: Nasr, Patrik, et al.
Publicado: (2017)

Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
por: Kaya, Eda, et al.
Publicado: (2022)

Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
por: Boursier, Jerome, et al.
Publicado: (2015)

Mechanisms of nonalcoholic fatty liver disease and implications for surgery
por: Kaufmann, Benedikt, et al.
Publicado: (2020)

FibroScan-AST Score Predicts 30-Day Mortality or Need for Mechanical Ventilation among Patients Hospitalized with COVID-19
por: Zelenika, Marko, et al.
Publicado: (2021)

Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis
por: Skladany, Lubomir, et al.
Publicado: (2021)

Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer
por: Cheng, Can, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications
por: Andronescu, Craita Isabela, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n558h71jtc9gfgaube533p07r3